Safety alerts
1 safety alerts appeared in South Korea during Week 17, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
South Korea medical device regulatory intelligence, Week 17, 2026.
Signals from 2026-04-20 to 2026-04-26, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for South Korea.
Signals
1
Sources
1
Index status
Noindex
This report is visible for continuity, but it is excluded from search indexing until it reaches 5 qualifying signals.
EXECUTIVE SUMMARY
South Korea generated 1 qualifying medical device signal during Week 17, 2026. Safety alerts led the week with 1 signal, while FDA Warning Letters was the most active source. Philips recalls Trilogy Evo ventilators due to non-conforming foam that may degrade and pose health risks.
Key observations
Safety alerts accounted for 1 of 1 qualifying signals, making it the main review lane for the week.
The remaining signals were spread across smaller categories, suggesting a lower-concentration week.
FDA Warning Letters contributed 1 signal, so source-level follow-up should start there.
Trilogy appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.
Category interpretation
Recommended monitoring focus
- Review MFDS safety and recall activity for product categories that overlap your portfolio.
- Maintain weekly monitoring for South Korea, especially when low-volume weeks precede regulator database updates.
- Validate high-impact items against the original source before using them in quality or regulatory decision-making.
- Compare this week with the next completed week to separate one-off noise from sustained category movement.
Source-backed signal evidence
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
FDA Warning Letters·Safety alerts·
FDA Class I: Trilogy Evo, Material Numbers DS2110X11B (USA) and KR2110X15B (Korea) The Trilogy Evo ventilator provides continuous or intermittent positive pressure ventilation for the care of individuals who re (Philips Respironics, Inc.)
Philips recalls Trilogy Evo ventilators due to non-conforming foam that may degrade and pose health risks.
SourceSafety alerts
FDA Warning Letters·Safety alerts·
FDA Class I: Trilogy Evo, Material Numbers DS2110X11B (USA) and KR2110X15B (Korea) The Trilogy Evo ventilator provides continuous or intermittent positive pressure ventilation for the care of individuals who re (Philips Respironics, Inc.)
Philips recalls Trilogy Evo ventilators due to non-conforming foam that may degrade and pose health risks.
SourceTrack these signals continuously.
MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.